Search results for "Anticoagulation"

Results 91 - 100 of about 593 for "Anticoagulation".

Sort by: Relevance | Newest | Oldest

Reports and recommendations on clot concerns with adenovirus COVID-19 vaccines

Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23.
https://acphospitalist.acponline.org/weekly/archives/2021/04/21/1.htm
21 Apr 2021

Rivaroxaban after discharge may reduce thromboembolic risk in medically ill

An industry-funded trial that gave medical patients rivaroxaban for 45 days after hospital discharge found decreased risk for a composite end point of symptomatic venous thromboembolism, myocardial infarction, nonhemorrhagic stroke, and cardiovascular death compared to placebo.
https://acphospitalist.acponline.org/weekly/archives/2020/06/24/3.htm
24 Jun 2020

The puzzle of submassive PE

Treating the middle of the pulmonary embolism spectrum can be tricky.
https://acphospitalist.acponline.org/archives/2020/06/the-puzzle-of-submassive-pe.htm
15 Jun 2020

Guidance released on acute care, periprocedural management of patients on NOACs

The American Heart Association's scientific statement offers recommendations on monitoring and reversal of non-vitamin K antagonist oral anticoagulants (NOACs), among other topics.
https://acphospitalist.acponline.org/weekly/archives/2017/02/15/4.htm
15 Feb 2017

COVID-19 research focuses on steroids, clots, hydroxychloroquine, zinc

Steroids' effects varied by C-reactive protein level, clots occurred despite prophylaxis, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.
https://acphospitalist.acponline.org/weekly/archives/2020/07/29/1.htm
29 Jul 2020

Problem of PPIs complicated by COVID-19

Despite quality improvement efforts, there's still uncertainty regarding proton-pump inhibitors.
https://acphospitalist.acponline.org/archives/2021/04/problem-of-ppis-complicated-by-covid-19.htm
15 Apr 2021

Adherence to labeling for NOACs may be crucial in patients with kidney disease

Overdosing of non-vitamin K antagonist oral anticoagulants (NOACs) was common among patients with severe kidney disease, while a significant proportion of patients without renal disease were underdosed, a study found.
https://acphospitalist.acponline.org/weekly/archives/2017/06/07/1.htm
7 Jun 2017